It aimed to compare the efficacy of these two different modes of LD application, the conventional LD/CD administration versus LD/CD with the COMT-inhibitor EN in one tablet (LD/CD/EN) in early PD patients with a need for LD therapy. The gene discussed is COMT; the disease is Parkinson disease.